Skip to main content

Table 4 Composition of CLNM assessment factors for PTC patients

From: Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study

Factors

P values

OR

95% CI

B

Risk score

Sex

<0.001

    

 Male

 

1.87

1.516-2.307

0.626

3.2

 Female

 

1.0

(reference)

 

0

Age (years)

<0.001

    

 ≤35

 

3.788

2.935-4.890

1.332

6.9

 36–42

 

2.118

1.641-2.734

0.75

3.9

 43–50

 

1.552

1.196-2.015

0.44

2.3

 >50

 

1.0

(reference)

 

0

TD (cm)

<0.001

    

 ≤1

 

1.0

(reference)

 

0

 >1 to ≤2

 

2.168

1.756-2.677

0.774

4.0

 >2 to ≤4

 

2.531

1.686-3.798

0.929

4.8

 >4

 

3.601

0.654-19.827

1.281

6.6

Tumor mulifocality

<0.001

    

 Single-focal

 

1.0

(reference)

 

0

 Multifocal

 

1.395

1.163-1.672

0.27

1.7

Vascular invasion

<0.001

    

 Yes

 

6.221

3.835-10.091

1.828

9.4

 No

 

1.0

(reference)

 

0

Number of lymph nodes in central region

<0.001

    

 0-5

 

1.0

(reference)

 

0

 6-8

 

1.93

1.503-2.477

0.657

3.4

 9-12

 

2.369

1.844-3.045

0.863

4.4

 >12

 

2.869

2.213-3.721

1.054

5.4

TPOAb concentration (uIU/ML)

0.033

    

 Lower (≤28)

 

1.424

1.119-1.813

0.354

1.8

 Low (>28 and ≤37)

 

1.326

1.007-1.747

0.282

1.5

 High (>37 and ≤59)

 

1.214

0.938-1.572

0.194

1.0

 Higher (>59)

 

1.0

(reference)

 

0

  1. Abbreviations: CLNM central lymph node metastasis, TD tumor diameter, TPOAb thyroid peroxidase antibody
Back to article page